The reduced expression and secretion of PGRN protein activate the NF-κB pathway, inducing EMT and ECM remodeling in bronchial epithelial cells, leading to airway remodeling and emphysema, and ultimately triggering COPD. Here, NFKB1 is linked to pulmonary emphysema.